Identification of heterozygous mutations of ABCC8 gene responsible for maturity-onset diabetes of the young with exome sequencing
Acta Diabetologica · 2024
DOI: 10.1007/s00592-024-02410-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Diabetologica, 2024. Verfasst von Yanxia Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Sulfonylurea Receptors, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Commission of Henan Province, Science and Technology Innovation Talents in Universities of Henan Province.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Although the MODY12 subtype, caused by ABCC8 mutations, is rare, it is highly sensitive to sulfonylureas. The identification of ABCC8 mutations in patients clinically diagnosed with MODY has the ability to contribute to the precise management of diabetes.
Methods
Genetic analysis of two families with MODY were conducted using whole-exome sequencing (WES) and Sanger sequencing. The spatial structures of the mutant proteins were constructed using MODELLER and PyMOL software to provide further evidence of pathogenicity.
Results
The heterozygous missense mutations V357I and R1393H in ABCC8 were found in probands of two unrelated MODY pedigrees, which co-segregated with the hyperglycemic phenotypes in these two pedigrees. Detection of the V357I mutation enabled the proband of family A to successfully transfer from insulin to sulfonylurea (SU). After 3 months of follow-up for the SU trial, the HbA1c level of proband A improved from 12.4% at the initial diagnosis to 7.20%. Proband B was treated with insulin because of pregnancy and poor islet function. In silico analysis indicated that the R1393H mutation resulted in a longer hydrogen bond distance to L1389 and cleavage of carbon-hydrogen bonds to V1395, A1390, and L1389.
Conclusions
We have described two pathogenic missense mutations in ABCC8 in Chinese families with MODY. Our findings support the heterogeneity in the clinical features of MODY12 caused by ABCC8 mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Genetic and Prenatal Diagnosis Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Department of Geriatric Endocrinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Institute of Monogenic Disease, School of Medicine, Huanghuai University, Zhumadian, China.
- Department of Emergency Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. 823096796@qq.com.
- Department of Geriatric Endocrinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. jylijh@163.com.
Förderung
- Health Commission of Henan Province
- Science and Technology Innovation Talents in Universities of Henan Province
Zitieren
APA
Liu, Y., Ren, S., Zhu, C., Chen, S., Zhang, H., Zhang, J., Li, J., & Jiang, Y. (2024). Identification of heterozygous mutations of ABCC8 gene responsible for maturity-onset diabetes of the young with exome sequencing. Acta Diabetologica. https://doi.org/10.1007/s00592-024-02410-1
Vancouver
Liu Y, Ren S, Zhu C, Chen S, Zhang H, Zhang J, et al. Identification of heterozygous mutations of ABCC8 gene responsible for maturity-onset diabetes of the young with exome sequencing. Acta Diabetologica. 2024. doi:10.1007/s00592-024-02410-1
BibTeX
@article{Liu2024,
author = {Liu, Yanxia and Ren, Shuxin and Zhu, Chaofeng and Chen, Sufang and Zhang, Huijuan and Zhang, Juan and Li, Jianhua and Jiang, Yanyan},
title = {Identification of heterozygous mutations of ABCC8 gene responsible for maturity-onset diabetes of the young with exome sequencing},
journal = {Acta Diabetologica},
year = {2024},
doi = {10.1007/s00592-024-02410-1}
}
EUVIMED